TENET HEALTHCARE CORP — Proxy Solicitation & Information Statement 2017

Mar 23, 2017

DEFA14A 1 d341407ddefa14a.htm DEFINITIVE ADDITIONAL MATERIALS Definitive Additional Materials

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934

(Amendment No. )

Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐	Preliminary Proxy Statement
☐	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐	Definitive Proxy Statement
☒	Definitive Additional Materials
☐	Soliciting Material under Rule 14a-12

Tenet Healthcare Corporation

(Name of Registrant as Specified in Its Charter)

Payment of Filing Fee (Check the appropriate box):

☒	No fee required.
☐	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
	(1)	Title of each class of securities to which transaction applies:
	(2)	Aggregate number of securities to which transaction applies:
	(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing
fee is calculated and state how it was determined):
	(4)	Proposed maximum aggregate value of transaction:
	(5)	Total fee paid:
☐	Fee paid previously with preliminary materials.
☐	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
	(1)	Amount Previously Paid:
	(2)	Form, Schedule or Registration Statement No.:
	(3)	Filing Party:
	(4)	Date Filed:

* Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Shareholder Meeting to Be Held on May 04, 2017

●
TENET HEALTHCARE CORPORATION
1445 ROSS AVENUE
SUITE 1400
DALLAS, TX 75202
●

Meeting Information
Meeting Type: Annual Meeting
For holders as of: March 13, 2017
Date: May 04,
2017 Time: 8:00 AM CDT
Location:	Tenet Corporate Headquarters
	1445 Ross Avenue, Suite 1400
	Dallas, Texas
75202
You are receiving this communication because you hold
shares in the above named company.
This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the
more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).
We encourage you to access and review all of the important information contained in the proxy materials before voting.
See the reverse side of this notice to obtain proxy materials and voting
instructions.

— Before You Vote —

How to Access the Proxy Materials

	Proxy Materials Available to VIEW or RECEIVE:
	1. Notice &
Proxy Statement 2. Form 10-K How to View
Online: Have the information that is printed in the box marked by the arrow (located on the following page) and visit: www.proxyvote.com. How to Request and Receive a PAPER or E-MAIL Copy: If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of
the following methods to make your request: 1) BY INTERNET : www.proxyvote.com 2) BY TELEPHONE :
1-800-579-1639 3) BY E-MAIL* :
sendmaterial@proxyvote.com * If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow (located on the following page) in the subject line. Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as
instructed above on or before April 20, 2017 to facilitate timely delivery.
— How To Vote —
Please Choose One of the Following Voting Methods
●	Vote In Person: Many shareholder
meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the
meeting, you will need to request a ballot to vote these shares. Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow available and follow the instructions. Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

	Voting items
	The Board of Directors recommends you vote FOR the
following:
	1.	Election of Directors
		Nominees
	1A	John P. Byrnes
	1B	Trevor Fetter
	1C	Brenda J. Gaines
	1D	Karen M. Garrison
	1E	Edward A. Kangas
	1F	J. Robert Kerrey
	1G	Richard R. Pettingill
	1H	Matthew J. Ripperger
	1I	Ronald A. Rittenmeyer
●	1J	Tammy Romo
	1K	Randolph C. Simpson
	1L	Peter M. Wilver
	The Board of Directors recommends you vote FOR the following
proposal:
	2.	Proposal to approve, on an advisory basis, the company’s
executive compensation.

| The Board of Directors recommends you vote 1 YEAR on the following
proposal: | |
| --- | --- |
| 3. | Proposal to approve, on an advisory basis, the option of every “1 year”, “2 years” or “3 years” for future advisory votes on executive compensation. |
| The Board of Directors recommends you vote FOR proposals 4. and 5. | |
| 4. | Proposal to approve the material terms of the performance goals under the Third Amended Tenet Healthcare Corporation Annual Incentive Plan. |
| 5. | Proposal to ratify the selection of Deloitte & Touche as independent registered public accountants for the year ending December 31, 2017. |
| NOTE: Such other business as may properly come before the meeting or any adjournment thereof. | |